Allurion Technologies (ALURD) Cash from Operations (2022 - 2026)

Allurion Technologies (ALURD) Cash from Operations (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn 1.32 Bn
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 581.00 Mn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 2.57 Bn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 348.00 Mn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn 43.80 Mn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn 290.00 Mn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 525.60 Mn
8 Smith & Nephew 28.19 Bn 27.62 Bn - -
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn 213.94 Mn
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn -3.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.22 Mn
Mar 31, 2026 -3.22 Mn
Dec 31, 2025 -5.32 Mn
Dec 31, 2025 -5.32 Mn
Sep 30, 2025 -6.53 Mn
Sep 30, 2025 -6.53 Mn
Jun 30, 2025 -7.63 Mn
Jun 30, 2025 -7.63 Mn
Mar 31, 2025 -9.47 Mn
Mar 31, 2025 -9.47 Mn
Dec 31, 2024 -13.27 Mn
Dec 31, 2024 -13.27 Mn
Sep 30, 2024 -11.43 Mn
Sep 30, 2024 -11.43 Mn
Jun 30, 2024 -9.00 Mn
Jun 30, 2024 -9.00 Mn
Mar 31, 2024 -8.60 Mn
Mar 31, 2024 -8.60 Mn
Dec 31, 2023 -20.90 Mn
Dec 31, 2023 -20.90 Mn